In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L-749,345) with those of imipenem, amoxicillin-clavulanate, and ciprofloxacin against 5,558 recent clinical isolates from 11 North American medical centers. We confirmed the greater...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Fuchs, Peter C., Barry, Arthur L., Brown, Steven D.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2001
主題:	Susceptibility
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90573/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353653/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1915-1918.2001
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!